Recommended pre-submission checks
Powered by 

Clinical Immunology Communications Journal Specifications
Indexed in the following public directories
Scopus
DOAJ
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 1750 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Clinical Immunology Communications ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Immunology Communications
Secondary immunodeficiency after B-cell depletion: Mechanisms, clinical manifestations, monitoring, and management
- 1 Dec 2026
- Clinical Immunology Communications
Anti-DFS70 antibodies are associated with acute Epstein-Barr virus infection: a pilot study
- 1 Dec 2026
- Clinical Immunology Communications
Recurrent homozygous FASLG pathogenic variant in an unrelated consanguineous Moroccan family with ALPS: a possible North African founder allele
- 1 Dec 2026
- Clinical Immunology Communications
HIV-1/HTLV-1 coinfection drives coordinated adaptive and innate immune dysregulation associated with increased risk of disease progression: a pilot exploratory study
- 1 Dec 2026
- Clinical Immunology Communications
Towards broadly protective hantavirus vaccine: Immunological barriers, structural vaccinology and one health perspectives
- 1 Dec 2026
- Clinical Immunology Communications
Rapid suppression of unresolving disseminated coccidioidomycosis infection with combined IL-15 super-agonist (N-803) and invariant natural killer T cell therapy
- 1 Dec 2026
- Clinical Immunology Communications
Secondary immunodeficiency after B-cell depletion: Mechanisms, clinical manifestations, monitoring, and management
- 1 Dec 2026
- Clinical Immunology Communications
Anti-DFS70 antibodies are associated with acute Epstein-Barr virus infection: a pilot study
- 1 Dec 2026
- Clinical Immunology Communications
Recurrent homozygous FASLG pathogenic variant in an unrelated consanguineous Moroccan family with ALPS: a possible North African founder allele
- 1 Dec 2026
- Clinical Immunology Communications
HIV-1/HTLV-1 coinfection drives coordinated adaptive and innate immune dysregulation associated with increased risk of disease progression: a pilot exploratory study
- 1 Dec 2026
- Clinical Immunology Communications
Towards broadly protective hantavirus vaccine: Immunological barriers, structural vaccinology and one health perspectives
- 1 Dec 2026
- Clinical Immunology Communications
Rapid suppression of unresolving disseminated coccidioidomycosis infection with combined IL-15 super-agonist (N-803) and invariant natural killer T cell therapy
- 1 Dec 2026
- Clinical Immunology Communications